Fortis-owned SRL Diagnostics puts in new strategy to increase revenue

A plan of setting up 100 collection centres in 100 days is on track and there is no change in plan as result of IHH Healthcare's acquisition of majority stake in Fortis Healthcare, says SRL CEO

Fortis-owned SRL Diagnostics is putting in place a strategy for increasing revenue and reach with a focus on preventive tests and loyalty plan. 

SRL Diagnostics' (SRL) revenue and margin growth has trailed those of its peers and the new strategy would enable it to expand its business. The move comes at a time when the central government is considering price caps on diagnostic tests. SRL does not support price caps as the diagnostic test is a service and not a product.

SRL  chief executive officer Arindam Haldar said the plan of setting up 100 collection centres in 100 days is on track and there is no